Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Tax Provisions (2021 - 2023)

Historic Tax Provisions for Silo Pharma (SILO) over the last 3 years, with Q1 2023 value amounting to $906396.0.

  • Silo Pharma's Tax Provisions rose 5033.71% to $906396.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $24876.0 for FY2021, which is N/A changed from last year.
  • Silo Pharma's Tax Provisions amounted to $906396.0 in Q1 2023, which was up 5033.71% from $602909.0 recorded in Q1 2022.
  • Over the past 5 years, Silo Pharma's Tax Provisions peaked at $906396.0 during Q1 2023, and registered a low of $5743.0 during Q4 2021.
  • For the 3-year period, Silo Pharma's Tax Provisions averaged around $383545.2, with its median value being $311021.0 (2021).
  • Over the last 5 years, Silo Pharma's Tax Provisions had its largest YoY gain of 5033.71% in 2023, and its largest YoY loss of 5033.71% in 2023.
  • Over the past 3 years, Silo Pharma's Tax Provisions (Quarter) stood at $5743.0 in 2021, then skyrocketed by 10398.15% to $602909.0 in 2022, then skyrocketed by 50.34% to $906396.0 in 2023.
  • Its last three reported values are $906396.0 in Q1 2023, $602909.0 for Q1 2022, and $5743.0 during Q4 2021.